Published in Eur J Surg Oncol on December 01, 2002
Immediate re-resection of T1 incidental gallbladder carcinomas: a survival analysis of the German Registry. Surg Endosc (2008) 2.20
Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol (2011) 1.13
Significance of extensive surgery including resection of the pancreas head for the treatment of gallbladder cancer--from the perspective of mode of lymph node involvement and surgical outcome. World J Surg (2006) 0.97
Radical resection for T1b gallbladder cancer: a decision analysis. HPB (Oxford) (2009) 0.92
New advances in the management of biliary tract cancer. HPB (Oxford) (2007) 0.88
Clinicopathological features of gallbladder papillary adenocarcinoma. Medicine (Baltimore) (2014) 0.77
Surgical approach does not influence the outcome of incidental gallbladder carcinoma. Int J Clin Exp Med (2015) 0.76
Impact of Type of Surgery on Survival Outcome in Patients With Early Gallbladder Cancer in the Era of Minimally Invasive Surgery: Oncologic Safety of Laparoscopic Surgery. Medicine (Baltimore) (2016) 0.76
Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ (1993) 3.26
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. Ann Oncol (2004) 1.95
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol (2009) 1.93
Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg (2007) 1.85
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol (2001) 1.64
Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial. Ann Oncol (2003) 1.62
Detection of dysplastic lesions by fluorescence in a model of colitis in rats after previous photosensitization with 5-aminolaevulinic acid. Endoscopy (1998) 1.62
KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab. Br J Surg (2012) 1.60
Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma. Br J Surg (2011) 1.60
Papillary muscle shortening for mitral valve reconstruction in patients with ischaemic mitral insufficiency. Eur Heart J (1998) 1.50
Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma. Br J Cancer (2003) 1.48
Second-line treatment of advanced gastric cancer with oxaliplatin plus raltitrexed. Onkologie (2003) 1.41
Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer. Oncology (1999) 1.38
Neurophysiology and functional neuroanatomy of pain perception. J Clin Neurophysiol (2000) 1.34
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann Oncol (2009) 1.26
Differential coding of pain intensity in the human primary and secondary somatosensory cortex. J Neurophysiol (2001) 1.22
HER 2/neu protein expression in colorectal cancer. BMC Cancer (2006) 1.18
Communication: papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association?TITLE. J Invest Dermatol (2000) 1.16
Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. Eur J Surg Oncol (2009) 1.13
The use of a breast symmetry index for objective evaluation of breast cosmesis. Breast (2007) 1.12
Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. Eur J Surg Oncol (2008) 1.11
A simplified technique for the management of acquired stenosis of the external auditory canal. J Laryngol Otol (1980) 1.09
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study). Ann Oncol (2014) 1.07
Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. Br J Cancer (1998) 1.06
Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol (1994) 1.06
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. Br J Cancer (1999) 1.02
Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer. J Clin Oncol (1999) 1.02
MRP and MDR1 gene expression in primary breast carcinomas. Clin Cancer Res (1996) 0.97
Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg (2009) 0.95
It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients. Breast Cancer Res Treat (1998) 0.94
Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies. J Cancer Res Clin Oncol (1992) 0.93
MDR1 gene expression and its clinical relevance in primary gastric carcinomas. Cancer (1993) 0.92
Side effects during chemotherapy predict tumour response in advanced colorectal cancer. Br J Cancer (2005) 0.92
Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. J Thromb Haemost (2010) 0.90
Parenchymal liver injury in orthotopic liver transplantation. Transplantation (2000) 0.90
Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer. Br J Cancer (2002) 0.90
MDR1 gene expression in primary colorectal carcinomas. Br J Cancer (1993) 0.89
A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma. Cancer (2000) 0.89
Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial. Am J Transplant (2006) 0.89
Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score. Eur J Clin Invest (2009) 0.89
Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C. Breast Cancer Res Treat (1993) 0.88
Quantification of blood flow in the carotid arteries: comparison of Doppler ultrasound and three different phase-contrast magnetic resonance imaging sequences. Invest Radiol (2001) 0.88
Behavioural relevance modulates access to spatial working memory in humans. Eur J Neurosci (2001) 0.88
Coincidence of Crohn's disease and a high-risk gastrointestinal stromal tumor of the terminal ileum. Digestion (1999) 0.88
Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trial. Cancer (2001) 0.87
Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer. Anticancer Res (2007) 0.87
A phase I-II study of epirubicin, 5-fluorouracil, and leucovorin in advanced adenocarcinoma of the stomach. Cancer (1993) 0.86
Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-alpha production and accelerated IL-10 expression. FASEB J (1999) 0.86
Effects of positive end-expiratory pressure on hemodynamics and indocyanine green kinetics in patients after orthotopic liver transplantation. Crit Care Med (2000) 0.86
Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation. Br J Cancer (2012) 0.85
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin. Br J Cancer (2000) 0.85
Classification of wounds at risk and their antimicrobial treatment with polihexanide: a practice-oriented expert recommendation. Skin Pharmacol Physiol (2011) 0.85
Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study. J Clin Oncol (1997) 0.85
[Abdominal dressing -- a new standard in therapy of the open abdomen following secondary peritonitis?]. Zentralbl Chir (2006) 0.85
MDR1 gene expression and prognostic factors in primary breast carcinomas. Eur J Cancer (1991) 0.85
Three-dimensional video-analysis of facial movements in healthy volunteers. Br J Plast Surg (2003) 0.84
Morphology and hemodynamics in dissection of the descending aorta. Assessment with MR imaging. Acta Radiol (2000) 0.84
Selective resection of colorectal liver metastases. Eur J Surg Oncol (2006) 0.84
Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin Transplant (2005) 0.84
Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy. Ann Oncol (2001) 0.84
Phase II study of amonafide in advanced breast cancer. Breast Cancer Res Treat (1991) 0.83
VAC and fistula formation. Colorectal Dis (2007) 0.83
Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinoma. Eur J Cancer (1995) 0.83
Hemorrhoidal artery ligation (HAL) and rectoanal repair (RAR): retrospective analysis of 408 patients in a single center. Tech Coloproctol (2014) 0.83
Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer. Cancer (1994) 0.82
Administration of proteolytic enzymes bromelain and trypsin diminish the number of CD4+ cells and the interferon-gamma response in Peyer's patches and spleen in endotoxemic balb/c mice. Cell Immunol (2002) 0.82
Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference. Eur J Surg Oncol (2012) 0.82
Impaired cerebral oscillatory processing in hepatic encephalopathy. Clin Neurophysiol (2007) 0.82
Liver transplantation for potassium dichromate poisoning. N Engl J Med (1998) 0.82
Organ survival after primary dysfunction of liver grafts in clinical orthotopic liver transplantation. Transpl Int (2000) 0.82
Simulated bone erosions in a hand phantom: detection with conventional screen-film technology versus cesium iodide-amorphous silicon flat-panel detector. Radiology (2000) 0.81
General compliance after liver transplantation for alcoholic cirrhosis. Transpl Int (2000) 0.81
Interleukin-1-beta, tumor necrosis factor-alpha, insulin secretion and oral glucose tolerance in non-diabetic siblings of children with IDDM. Indian J Pediatr (2000) 0.81
Are there ethnic differences of facial movements between Europeans and Asians? Br J Plast Surg (2005) 0.81
Clinical efficacy of a new monofilament fibre-containing wound debridement product. J Wound Care (2011) 0.81
The role of biological agents in the resection of colorectal liver metastases. Clin Oncol (R Coll Radiol) (2012) 0.81
Expression of the multidrug resistance protein (MRP1) in breast cancer. Anticancer Res (2000) 0.80
Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor. Br J Cancer (1996) 0.80
Improvement of cardiac output and liver blood flow and reduction of pulmonary vascular resistance by intravenous infusion of L-arginine during the early reperfusion period in pig liver transplantation. Transplantation (1997) 0.80
Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor. Breast Cancer Res Treat (1999) 0.80
Prenephrectomy tissue typing using donor lymph node cells: a reliable and safe way of shortening cadaver kidney ischemia time. Transplant Proc (1991) 0.80
Heart retransplantation: institutional results of a series of 31 cases. Transplant Proc (2001) 0.80
Fluoride varnishes and caries development in primary tooth enamel: an in vitro study. ASDC J Dent Child (2002) 0.79
[Vagal stimulation - a new possibility for conservative treatment of peripheral arterial occlusion disease]. Zentralbl Chir (2011) 0.79
A multicenter study to assess outcome following a switch in the primary immunosuppressant from cyclosporin (CYA) to tacrolimus (TAC) in lung recipients. J Heart Lung Transplant (2001) 0.79
Amonafide as first-line chemotherapy for metastatic breast cancer. Eur J Cancer (1994) 0.79
Is long-term functional outcome after lung volume reduction surgery predictable? Eur J Cardiothorac Surg (2000) 0.79
Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation (2001) 0.79
Surgery and transplantation - Guidelines on Parenteral Nutrition, Chapter 18. Ger Med Sci (2009) 0.79
Target vessel revascularization without cardiopulmonary bypass in elderly high-risk patients. Ann Thorac Surg (2001) 0.78
Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas. Br J Cancer (1997) 0.78
[Prevention of adhesions in abdominal surgery. A dose finding study with streptokinase/streptodornase]. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir (1990) 0.78